Marketers Sponsored by
Johnson & Johnson today announced sales of $16.6 billion for the second quarter of 2011, an increase of 8.3% as compared to the second quarter of 2010. Operational results increased 2.6% and the positive impact of currency was 5.7%. Domestic sales increased 0.1%, while international sales increased 15.9%, reflecting operational growth of 4.9% and a positive currency impact of 11.0%.
Positive contributors to operational results were Neutrogena, Le Petit Marseillais and Aveeno skin care products; international sales of over-the-counter medicines and nutritionals; and baby care products.